In its Q2 2026 investor letter, Conestoga Capital Advisors highlighted Balchem Corporation (NASDAQ:BCPC).
Balchem Corporation (NASDAQ:BCPC) is a specialty chemicals company that serves nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets
On August 5, 2026, Balchem Corporation (NASDAQ:BCPC) closed at $178.79 per share. One-month return of Balchem Corporation (NASDAQ:BCPC) was 9.33%, and its shares gained 12.13% over the past 52 weeks. Balchem Corporation (NASDAQ:BCPC) has a market capitalization of $5.7 billion.
Conestoga Capital Advisors stated the following regarding Balchem Corporation (NASDAQ:BCPC) in its Q2 2026 investor letter: “Balchem Corporation (NASDAQ:BCPC) develops specialty ingredients for the nutrition, food, and healthcare markets. The stock underperformed despite another quarter of solid financial results as investors focused on the potential for higher costs associated with the war in the Gulf. While first quarter sales increased 8%, elevated expectations left little room for upside despite continued strong execution.